TDF 300mg / 3TC 300mg, tab.

STD DORATELA1T-

Valid Article

Former Code(s): DORAZYN1001 DORATELA3T3
6.4.2.5 - Fixed-dose combinations of antiretroviral medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR12
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

TENOFOVIR (TDF) / LAMIVUDINE (3TC)

Therapeutic Action

Fixed-dose combination (FDC) of two antiretrovirals, nucleoside reverse-transcriptase inhibitors (NRTI)

Indications

HIV infection according to strengths recommended by WHO.

Pre-Exposure Prophylaxis (PrEP)

Instructions for use

Should be used in combination with other antiretrovirals.

Can be used for PrEP.

Storage

Below 25ºC